ENDRA Life Sciences Statistics
Share Statistics
ENDRA Life Sciences has 562.21K
shares outstanding. The number of shares has increased by -73.65%
in one year.
| Shares Outstanding | 562.21K |
| Shares Change (YoY) | -73.65% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 0.01% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,021 |
| FTD / Avg. Volume | 2.13% |
Short Selling Information
The latest short interest is 44.66K, so 8.32% of the outstanding
shares have been sold short.
| Short Interest | 44.66K |
| Short % of Shares Out | 8.32% |
| Short % of Float | 8.32% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -0.11 and the forward
PE ratio is null.
ENDRA Life Sciences's PEG ratio is
0.
| PE Ratio | -0.11 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | 34.7 |
| PB Ratio | 0.49 |
| P/FCF Ratio | -0.17 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for ENDRA Life Sciences.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.67,
with a Debt / Equity ratio of 0.23.
| Current Ratio | 5.67 |
| Quick Ratio | 5.67 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | -0.05 |
| Debt / FCF | -0.08 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-547,997.48 |
| Employee Count | 21 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -98.92% in the
last 52 weeks. The beta is 0.19, so ENDRA Life Sciences's
price volatility has been higher than the market average.
| Beta | 0.19 |
| 52-Week Price Change | -98.92% |
| 50-Day Moving Average | 4.15 |
| 200-Day Moving Average | 20.16 |
| Relative Strength Index (RSI) | 62.06 |
| Average Volume (20 Days) | 141,993 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Net Income | -11.51M |
| EBITDA | -11.3M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -56.94 |
Full Income StatementBalance Sheet
The company has 3.23M in cash and 584.42K in
debt, giving a net cash position of 2.65M.
| Cash & Cash Equivalents | 3.23M |
| Total Debt | 584.42K |
| Net Cash | 2.65M |
| Retained Earnings | -103.44M |
| Total Assets | 4.45M |
| Working Capital | 2.83M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -7.4M
and capital expenditures -16K, giving a free cash flow of -7.42M.
| Operating Cash Flow | -7.4M |
| Capital Expenditures | -16K |
| Free Cash Flow | -7.42M |
| FCF Per Share | -36.7 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
